ADAP Insider Holders & Insider Ownership - Adaptimmune Therapeutics PLC

List of insiders holdings for Adaptimmune Therapeutics PLC:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
EcoR1 Capital LLC 10% Owner	2024-03-26 12:00:09	0 164,424,420	164,424,420	Form 3
New Enterprise Associates 14 L.P. NEA Partners 14 L.P. NEA 14 GP LTD 10% Owner	2024-04-02 20:38:07	102,478,672 0	102,478,672	Form 13D
Sonsini Peter W. 10% Owner	2020-01-28 16:55:02	0 102,478,668	102,478,668	Form 4
SANDELL SCOTT D 10% Owner	2020-01-28 16:54:19	0 102,478,668	102,478,668	Form 4
Florence Anthony A. Jr. 10% Owner	2020-01-28 16:52:58	0 102,478,668	102,478,668	Form 4
BASKETT FOREST 10% Owner	2020-01-28 16:51:48	0 102,478,668	102,478,668	Form 4
KERINS PATRICK J 10% Owner	2018-09-10 16:48:11	0 82,978,668	82,978,668	Form 4
BARRETT M JAMES 10% Owner	2018-09-10 16:45:40	0 82,978,668	82,978,668	Form 4
Weller Harry R 10% Owner	2016-01-04 17:21:47	0 59,269,000	59,269,000	Form 3
KOLLURI KRISHNA KITTU 10% Owner	2016-01-04 17:19:17	0 59,269,000	59,269,000	Form 3
ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC ISALY SAMUEL D Director	2018-10-10 14:37:50	29,407,858 0	29,407,858	Form 13D
ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director	2018-10-10 14:37:50	29,407,858 0	29,407,858	Form 13D
Laing Ian Michael Director	2018-02-02 16:48:04	20,346,675 0	20,346,675	Form 13G
BARRIS PETER J 10% Owner	2018-09-10 16:46:04	0 12,000,000	12,000,000	Form 4
Viswanathan Ravi 10% Owner	2018-09-10 16:49:56	0 12,000,000	12,000,000	Form 4
Piccina Cintia Chief Commercial Officer	2024-03-18 17:00:12	6,219,696 0	6,219,696	Form 4
Thompson Peter A. Director	2018-06-06 18:16:17	0 4,901,310	4,901,310	Form 4
Wood Gavin Chief Financial Officer	2024-01-17 17:01:14	3,109,848 0	3,109,848	Form 4
TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer	2024-01-17 17:01:40	3,109,848 0	3,109,848	Form 4
Brewer Joanna Elizabeth Chief Scientific Officer	2024-01-17 17:02:11	3,109,848 0	3,109,848	Form 4
MOTT DAVID M Director	2023-07-03 17:01:34	1,462,927 0	1,462,927	Form 4
Alleva Lawrence M Director	2023-07-03 17:02:08	1,077,756 0	1,077,756	Form 4
Sigal Charles Elliott Director	2023-07-03 17:02:43	933,317 0	933,317	Form 4
Noble James Director	2022-07-01 17:02:06	710,711 0	710,711	Form 4
Allen Andrew R Director	2023-07-05 17:03:13	547,296 0	547,296	Form 4
Duncan Barbara Gayle Director	2022-07-01 17:01:14	500,000 0	500,000	Form 4
Zaks Tal Zvi Director	2022-07-01 17:03:51	500,000 0	500,000	Form 4
Furey John Director	2023-07-03 17:04:04	500,000 0	500,000	Form 4
Hegde Priti Director	2023-07-05 17:05:16	488,586 0	488,586	Form 4
Knowles Jonathan Kenneth Charles Director	2016-08-12 18:20:38	217,222 0	217,222	Form 4
Kerr Giles Francis Bertram Director	2019-07-03 17:00:49	124,000 0	124,000	Form 4
Hege Kristen Director	2024-01-17 17:03:04	81,906 0	81,906	Form 4
Menzel Garry E Director	2023-07-10 17:01:03	75,056 0	75,056	Form 4
Rawcliffe Adrian Chief Executive Officer	2024-01-17 17:31:52	44,848 0	44,848	Form 4
Behbahani Ali Director	2024-01-17 17:06:47	40,950 0	40,950	Form 4
Bertrand William C JR Chief Operating Officer	2024-01-17 17:30:20	20,201 0	20,201	Form 4
Norry Elliot Chief Medical Officer	2024-01-17 17:31:27	19,257 0	19,257	Form 4
Lunger John Chief Patient Supply Officer	2024-01-17 17:30:50	19,015 0	19,015	Form 4
Amado Rafael President, R&D	2019-08-07 21:00:43	17,237 0	17,237	Form 4
Binder-Scholl Gwendolyn Knowlton Chief Technology Officer	2019-01-16 21:31:56	2487 0	2487	Form 4
Garone Michael Interim CFO	2019-10-01 21:30:28	0 0	0	Form 3

Insider Holders & Insider Ownership - Adaptimmune Therapeutics PLC (ADAP)